Get Premium to unlock powerful stock data
NAS:TVTX (USA)  
Travere Therapeutics Inc logo

Travere Therapeutics Inc

$ 24.86 +0.63 (+2.6%) 03:02 PM EST
P/E:
At Loss
P/B:
7.59
Market Cap:
$ 1.58B
Enterprise V:
$ 1.34B
Volume:
256.93K
Avg Vol (2M):
872.47K
Also Trade In:
Volume:
256.93K
Market Cap $:
1.58B
PE Ratio:
At Loss
Avg Vol (2-Month):
872.47K
Enterprise Value $:
1.34B
PB Ratio:
7.59
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Travere Therapeutics Inc
NAICS : 325411 SIC : 2834
3611 Valley Centre Drive, Suite 300, San Diego, CA, USA, 92130
Description
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease.
Name Current Vs Industry Vs History
Cash-To-Debt 1.48
Equity-to-Asset 0.25
Debt-to-Equity 1.96
Debt-to-EBITDA -2.6
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.43
Distress
Grey
Safe
Beneish M-Score -3.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 47.98
9-Day RSI 50.48
14-Day RSI 50.52
6-1 Month Momentum % -24.9
12-1 Month Momentum % 59.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.28
Quick Ratio 5.23
Cash Ratio 5.05
Days Inventory 351.53
Days Sales Outstanding 22
Days Payable 629.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.7

Financials (Next Earnings Date:2022-07-29 Est.)

TVTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:TVTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 228.57
EPS (TTM) ($) -3.27
Beta 0.78
Volatility % 65.21
14-Day RSI 50.52
14-Day ATR ($) 1.511867
20-Day SMA ($) 23.935
12-1 Month Momentum % 59.77
52-Week Range ($) 12.75 - 31.65
Shares Outstanding (Mil) 63.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Travere Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More